In the present study, the serum levels of VEGF and MMP-9 in the pretreatment group of NSCLC with lymph node metastasis were significantly higher than in those without lymph node metastasis. The gene discussed is MMP9; the disease is metastatic malignant neoplasm in the lymph nodes.